These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 11459076

  • 1. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
    Jonkers N, Sarre S, Ebinger G, Michotte Y.
    J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
    [Abstract] [Full Text] [Related]

  • 2. Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.
    Shen H, Kannari K, Yamato H, Arai A, Matsunaga M.
    Tohoku J Exp Med; 2003 Mar; 199(3):149-59. PubMed ID: 12703659
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA, Mattern C, Häcker R, Tomaz C, Huston JP, Schwarting RK.
    Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
    [Abstract] [Full Text] [Related]

  • 5. Amantadine increases L-DOPA-derived extracellular dopamine in the striatum of 6-hydroxydopamine-lesioned rats.
    Arai A, Kannari K, Shen H, Maeda T, Suda T, Matsunaga M.
    Brain Res; 2003 May 16; 972(1-2):229-34. PubMed ID: 12711097
    [Abstract] [Full Text] [Related]

  • 6. Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.
    Treseder SA, Rose S, Summo L, Jenner P.
    J Neural Transm (Vienna); 2003 Mar 16; 110(3):229-38. PubMed ID: 12658372
    [Abstract] [Full Text] [Related]

  • 7. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A, Brotchie JM, Jones OT.
    Neurosci Res; 2010 Sep 16; 68(1):44-50. PubMed ID: 20542064
    [Abstract] [Full Text] [Related]

  • 8. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA, Rose S, Jenner P.
    Eur J Neurosci; 2001 Jan 16; 13(1):162-70. PubMed ID: 11135014
    [Abstract] [Full Text] [Related]

  • 9. In vivo microdialysis to determine the relative pharmacokinetics of drugs.
    Nakashima M, Zhao MF, Nakashima MN, Sakurai M, Sasaki H, Matsuyama K, Ichikawa M.
    Biol Pharm Bull; 1996 Jul 16; 19(7):988-94. PubMed ID: 8839975
    [Abstract] [Full Text] [Related]

  • 10. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
    Okada M, Nakao R, Hosoi R, Zhang MR, Fukumura T, Suzuki K, Inoue O.
    J Cereb Blood Flow Metab; 2011 Jan 16; 31(1):124-31. PubMed ID: 20407462
    [Abstract] [Full Text] [Related]

  • 11. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
    Sánchez-Pernaute R, Harvey-White J, Cunningham J, Bankiewicz KS.
    Mol Ther; 2001 Oct 16; 4(4):324-30. PubMed ID: 11592835
    [Abstract] [Full Text] [Related]

  • 12. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
    Buck K, Ferger B.
    Neurobiol Dis; 2008 Feb 16; 29(2):210-20. PubMed ID: 17920284
    [Abstract] [Full Text] [Related]

  • 13. Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
    Napolitano A, Zürcher G, Da Prada M.
    Eur J Pharmacol; 1995 Feb 06; 273(3):215-21. PubMed ID: 7737328
    [Abstract] [Full Text] [Related]

  • 14. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.
    Fisher A, Biggs CS, Eradiri O, Starr MS.
    Neuroscience; 2000 Feb 06; 95(1):97-111. PubMed ID: 10619466
    [Abstract] [Full Text] [Related]

  • 15. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
    Shimamura M, Shimizu M, Yagami T, Funabashi T, Kimura F, Kuroiwa Y, Misu Y, Goshima Y.
    Neuropharmacology; 2006 Jun 06; 50(8):909-16. PubMed ID: 16504219
    [Abstract] [Full Text] [Related]

  • 16. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
    Ciesielska A, Sharma N, Beyer J, Forsayeth J, Bankiewicz K.
    PLoS One; 2015 Jun 06; 10(4):e0122708. PubMed ID: 25860990
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB, Moore KE.
    Life Sci; 1976 Sep 01; 19(5):701-6. PubMed ID: 957902
    [No Abstract] [Full Text] [Related]

  • 18. Central action of benserazide after COMT inhibition demonstrated in vivo by PET.
    Tedroff J, Hartvig P, Bjurling P, Andersson Y, Antoni G, Långström B.
    J Neural Transm Gen Sect; 1991 Sep 01; 85(1):11-7. PubMed ID: 1867835
    [Abstract] [Full Text] [Related]

  • 19. Regulation of aromatic L-amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists.
    Zhu MY, Juorio AV, Paterson IA, Boulton AA.
    Br J Pharmacol; 1994 May 01; 112(1):23-30. PubMed ID: 7913379
    [Abstract] [Full Text] [Related]

  • 20. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    Tayarani-Binazir KA, Jackson MJ, Fisher R, Zoubiane G, Rose S, Jenner P.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):109-16. PubMed ID: 20303948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.